TP53 and glioblastoma: This sophisticated model integrates the activation of the KrasG12D oncogene, the deletion of p53 tumor suppressor genes, and the inclusion of the APCL/+ alteration to study the canonical Wnt pathway’s activation and its role in the regulation of glioblastoma tumorigenesis.